Regenero

Search results

• University of los Andes Researcher Publishes Findings in Pharmaceutics (Oral Administration as a Potential Alternative for the Delivery of Small Extracellular Vesicles)

  Francisca Alcayaga-Miranda & Maroun Khoury

  13/03/23

  1 item of Media coverage

  Press/Media

• Findings from University of los Andes Advance Knowledge in Acute Respiratory Distress Syndrome (Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome)

  Francisca Alcayaga-Miranda & Maroun Khoury

  10/02/23

  1 item of Media coverage

  Press/Media

• US Patent Issued to UNIVERSIDAD DE LOS ANDES, CELLS FOR CELLS on Jan. 31 for "Gelatin polymer derived from natural sources of cold-adapted marine species and uses thereof" (Chilean Inventors)

  Javier Enrione & Juan Pablo Acevedo

  1/02/23

  1 item of Media coverage

  Press/Media

• In memoriam 2022: Peruvian and world cultural personalities who passed away

  Juan Pablo Acevedo

  1/01/23

  1 item of Media coverage

  Press/Media

• How to (Not) Scale a Nonprofit (SSIR)

  Juan Pablo Acevedo

  8/09/22

  1 item of Media coverage

  Press/Media

• How (Not) to Scale a Nonprofit

  Juan Pablo Acevedo

  7/09/22

  1 item of Media coverage

  Press/Media

• Patient Dosed With Mesenchymal Stem Cell-Derived Therapy for Osteoarthritis

  Maroun Khoury

  25/07/22

  1 item of Media coverage

  Press/Media

• CELLS for CELLS Treats the First-Ever Patient with an Exosome-Produced Therapy for Osteoarthritis

  Maroun Khoury

  19/07/22

  1 item of Media coverage

  Press/Media

• Cells for Cells treats first patient with exosome-produced therapy for osteoarthritis

  Maroun Khoury

  19/07/22

  1 item of Media coverage

  Press/Media

• CELLS For CELLS Treats The First-Ever Patient With An Exosome-Produced Therapy For Osteoarthritis

  Maroun Khoury

  18/07/22 → 19/07/22

  19 items of Media coverage

  Press/Media

• $32M settlement reached; Compensation for Gold King Mine toxic spill damages

  Juan Pablo Acevedo

  17/06/22

  1 item of Media coverage

  Press/Media

• $32 million settlement reached over toxic Gold King Mine spill damages

  Juan Pablo Acevedo

  16/06/22

  4 items of Media coverage

  Press/Media

• Form 485APOS SPDR INDEX SHARES FUNDS

  Juan Pablo Acevedo

  19/05/22

  1 item of Media coverage

  Press/Media

• Cell for Cells starts cell therapy operations in the U.S. and closes agreement with the University of Miami

  Maroun Khoury

  18/02/22

  1 item of Media coverage

  Press/Media

• Revolutionary Chilean center will research the generation of new tissues and the use of cells to treat patients

  Maroun Khoury

  2/01/22

  1 item of Media coverage

  Press/Media

• COMBAT AVIATION ADVISORS PARTICIPATE IN AIRDROP COMPETITION

  Juan Pablo Acevedo

  16/12/21

  1 item of Media coverage

  Press/Media

• Combat Aviation Advisors participate in airdrop competition

  Juan Pablo Acevedo

  15/12/21

  1 item of Media coverage

  Press/Media

• US Patent Issued to Cells for Cells on June 22 for "Anti-angiogenic therapy based on exosomes derived from menstrual stem cells" (Chilean Inventors)

  Maroun Khoury

  23/06/21

  1 item of Media coverage

  Press/Media

• North Providence’s champions helped brighten a difficult 2020

  Juan Pablo Acevedo

  30/12/20

  1 item of Media coverage

  Press/Media

• NP ’s champs helped brighten rough 2020; NPHS swimmers made waves before pandemic made news

  Juan Pablo Acevedo

  30/12/20

  1 item of Media coverage

  Press/Media

• NP’s champs helped brighten rough 2020

  Juan Pablo Acevedo

  30/12/20

  1 item of Media coverage

  Press/Media

• More than S/73 million executed the Regional Freedom Government in various works for the population

  Juan Pablo Acevedo

  26/12/20

  1 item of Media coverage

  Press/Media

• VEINTIS™ the tissue-engineered vascular graft developed by Cells for Cells, wins the 2020 National Innovation Prize

  Juan Pablo Acevedo

  12/11/20 → 13/11/20

  2 items of Media coverage

  Press/Media

• Characterization of menstrual stem cells: angiogenic effect, migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells.

  Patricia Alejandra Luz Crawford, Maroun Khoury & Francisca Alcayaga-Miranda

  17/10/20

  1 item of Media coverage

  Press/Media

• Australia Patent: Application for 'Anti-angiogenic therapy based on exosomes derived from menstrual stem cells' Lapses

  Maroun Khoury

  16/10/20

  1 item of Media coverage

  Press/Media